loadpatents
Patent applications and USPTO patent grants for Drace; Colene D..The latest application filed is for "use of agents that down-regulate expression of tanis and/or p21 waf1/cip1/sd1 genes, and use of agents that inhibit, degrade, sequester or prevent the neurotoxicity of gene product proteins of tanis and p21 waf1/cip1/sd1 genes".
Patent | Date |
---|---|
USE OF AGENTS THAT DOWN-REGULATE EXPRESSION OF TANIS AND/OR P21 Waf1/Cip1/Sd1 GENES, AND USE OF AGENTS THAT INHIBIT, DEGRADE, SEQUESTER OR PREVENT THE NEUROTOXICITY OF GENE PRODUCT PROTEINS OF TANIS AND P21 Waf1/Cip1/Sd1 GENES App 20100173852 - Drace; Colene D. ;   et al. | 2010-07-08 |
Method for treating glaucoma comprising administering .alpha.-lipoic acid Grant 7,718,697 - Drace , et al. May 18, 2 | 2010-05-18 |
High Throughput Assay For Human Rho Kinase Activity With Enhanced Signal-to-noise Ratio App 20080096238 - Sharif; Najam A. ;   et al. | 2008-04-24 |
High throughput assay for human Rho kinase activity App 20060115870 - Sharif; Najam A. ;   et al. | 2006-06-01 |
Use of agents that down-regulate expression of tanis and/or p21^Waf1/Cip1/Sd1 genes, and use of agents that inhibit, degrade, sequester or prevent the neurotoxicity of gene product proteins of tanis and p21^Waf1/Cip1/Sd1 genes App 20050137123 - Drace, Colene D. ;   et al. | 2005-06-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.